Globeflex Capital L P Horizon Therapeutics Public LTD CO Transaction History

Globeflex Capital L P

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$71.83 - $95.48 $342,054 - $454,675	-4,762 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$67.0 - $84.39 $739,680 - $931,665	-11,040 Reduced 69.86%	4,762 $348,000
Q3 2020 Nov 13, 2020	SELL	$55.23 - $79.93 $282,170 - $408,362	-5,109 Reduced 24.43%	15,802 $1.23 Million
Q2 2020 Aug 12, 2020	SELL	$30.2 - $56.98 $1.66 Million - $3.14 Million	-55,108 Reduced 72.49%	20,911 $1.16 Million
Q1 2020 May 13, 2020	SELL	$24.87 - $38.56 $864,406 - $1.34 Million	-34,757 Reduced 31.38%	76,019 $2.25 Million
Q4 2019 Feb 07, 2020	SELL	$25.43 - $36.67 $252,291 - $363,803	-9,921 Reduced 8.22%	110,776 $4.01 Million
Q3 2019 Nov 13, 2019	SELL	$23.0 - $27.97 $131,905 - $160,407	-5,735 Reduced 4.54%	120,697 $3.29 Million
Q2 2019 Aug 12, 2019	SELL	$22.81 - $28.48 $2,828 - $3,531	-124 Reduced 0.1%	126,432 $3.04 Million
Q1 2019 May 10, 2019	BUY	$19.49 - $29.01 $2.47 Million - $3.67 Million	126,556 New	126,556 $3.35 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Globeflex Capital L P, based on Form 13F filings with the SEC.

Stay updated on Globeflex Capital L P with notifications on news.